Status:
COMPLETED
Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy
Lead Sponsor:
Carmel Medical Center
Conditions:
Laparoscopic Surgical Procedures
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surg...
Eligibility Criteria
Inclusion
- Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.
- The patient is not participating in other medical study at present or in the last 30 days.
- The patient signed on an informed consent.
- Age 18 years and above.
- ASA (American Society of Anesthesiologists) physical status grade 1- 2.
Exclusion
- Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.
- The patient is participating in other medical experiment at present or in the last 30 days.
- Acute Pelvic Inflammatory Disease.
- Coumadin or Aspirin treatment.
- ASA physical status grade 3-4.
- Age \< 18 years.
- Significant arrythmias
- Analgesic treatment for chronic pain
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00433316
Start Date
February 1 2007
End Date
October 1 2007
Last Update
June 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Carmel Medical Center Ambulatory Gynecoendoscopic Unit
Haifa, Israel, 34362